Grant from National Institute on Drug Abuse to extend landmark study
Low levels of neuropeptide in babies’ cerebrospinal fluid linked to later diagnosis.
Researchers at Washington University School of Medicine are recruiting COVID-19 patients for a clinical trial that will examine whether an existing anti-depressant can be an effective treatment for COVID-19.
Eric Lenze, MD, and Caline Mattar, MD, have launched a study into whether a long-used antidepressant can reduce the likelihood that COVID-19 will turn deadly.
Research from Washington University in St. Louis is narrowing the gap in psychology’s understanding of suicidal thoughts in young people. The findings show that such thoughts begin as early as 9 and 10 years old.
Research focuses on precisely how the disease develops in the brain
Compelled by the potential to improve the lives of vulnerable children, emeritus trustee Walter Metcalfe and his wife, Cynthia, have committed nearly $4 million through outright and estate gifts to support the work of Joan L. Luby, MD, a highly regarded child psychiatrist.
Tapped for their work aimed at stemming opioid abuse and halting what has become an epidemic in the United States, researchers at Washington University School of Medicine in St. Louis have received federal grants totaling more than $10 million from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $11.5 million grant to lead a multicenter effort to understand how brain development in babies with Down syndrome differs from that in other babies.
Personalized brain maps could improve treatment for Parkinson’s disease, other neurological conditions